Financials
- Market Capitalization 1.78 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.15
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | -7.40% | +3.36% | -36.11% | 1.79 B USD | ||
| 2077 | PGEN Precigen, Inc. - Common Stock | 5.11 USD | -0.20% | -6.75% | +6.24% | +174.73% | 1.82 B USD | ||
| 2117 | IMCR Immunocore Holdings plc - American Depositary Shares | 33.60 USD | +0.39% | +1.94% | +17.44% | +0.36% | 1.71 B USD | ||
| 2120 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 6.75 USD | +3.69% | +18.42% | +36.09% | +158.62% | 1.74 B USD |